SogoTrade Research Center

For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
Johnson & Johnson
(NYSE: JNJ) Add to Portfolio
-0.57 (-0.38%)
as of Feb 20, 2020

Last 148.37
Change -0.57 (-0.38%)
Open 148.61
Prev. Close 148.94
Today's Range
147.40 149.38
52wk Range
126.10 154.50
Volume 7,465,000
Avg Volume 6,498,655
Sector SIC-2834 Pharmaceutical Preparations

Recent Headlines
The "Orthopedic Digit Implants Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to's offering. (full story)
JNJ: 148.37 (-0.57), SYK: 224.47 (-0.63), WMGIZ: 0.01 (unch)
The global Ophthalmic Devices Market size is expected to reach USD 33.99 billion by 2026, exhibiting a CAGR of 5.2% during the forecast period. The rising cases of visual impairment and blindness will spur demand for ophthalmic de (full story)
JNJ: 148.37 (-0.57), NVS: 96.29 (-0.93)
Daily Journal, a law publication in California, has named Simon Greenstone Panatier's $40 million verdict against Johnson & Johnson among the 2019 Top Verdicts in California. In September 2019, a California jury found that asbesto (full story)
DJCO: 294.20 (-2.40), JNJ: 148.37 (-0.57)
The global IoMT Market size is anticipated to reach USD 142.45 billion by 2026, with a CAGR of 28.9%, on account of the increasing prevalence of chronic diseases. This, coupled with the improving healthcare infrastructure and faci (full story)
BSX: 42.50 (-0.52), CSCO: 46.85 (+0.56), GE: 12.53 (-0.08), JNJ: 148.37 (-0.57), MDT: 113.86 (+0.09), SIEGY: 57.5500 (-0.0400)
Johnson & Johnson (NYSE: JNJ) today announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assist (full story)
JNJ: 148.37 (-0.57)
Performance Comparison
Name Today 3-Month 1-Year
JNJ -0.38% +5.69% +8.82%
Growth Rates
YTD +1.71%
1-Year +8.62%
3-Year +20.89%
5-Year +44.74%
10-Year +135.51%
© 2020 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.